TherapeuticsMD Inc. (TXMD)
Symbol Info
Listed Symbol TXMD
Name TherapeuticsMD Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $16,099,460
Latest Fiscal EPS $-0.59
Price Info
21 Day Moving Average $3.1362
21 Day EMA $3.253720
50 Day Moving Average $2.7282
50 Day EMA $2.997220
200 Day EMA $3.741990
200 Day Moving Average 3.909550
52 Week High $6.94
52 Week Low $1.82
52 Week Change $-45.037003
Alpha -0.001411
Beta 1.6940
Standard Deviation 0.177079
R2 0.108487
Periods 60
Share Information
10 Day Average Volume 3,447,691
20 Day Average Volume 2,674,027
30 Day Average Volume 3,197,202
50 Day Average Volume 3,168,035
Outstanding Shares 241,221,840
Float Shares 216,866,922
Percent Float 89.90%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 284
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 17,166,823
Institute Holdings Percent -
Institute Sold Previous 3 Months 23,218,655
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 24,354,918
Price Change
7 Day Price Change $0.2900000
7 Day Percent Change 8.48%
21 Day Price Change $0.8199999
21 Day Percent Change 28.37%
30 Day Price Change $0.9700000
30 Day Percent Change 35.40%
Month To Date Price Change $0.8200
Month To Date Percent 28.37%
90 Day Price Change $1.070000
90 Day Percent Change 40.53%
Quarter To Date $1.110000
Quarter To Date Percent 42.69%
180 Day Price Change $-1.81
180 Day Percent Change -32.79%
200 Day Price Change $-2.21
200 Day Percent Change -37.33%
Year To Date $-0.1
Year To Date Percent -2.62%
Profile
Description TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Details
Issue Type CS
Market Cap $894,933,026
Sec Type EQS
Auditor Grant Thornton LLP
Total Shares Outstanding 241,221,840
CEO Robert G. Finizio
Employees 241
Last Audit UQ
Classification
CIK 0000025743
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 6800 Broken Sound Parkway NW
Third Floor
Boca Raton, FL 33487
Website http://www.therapeuticsmd.com
Facisimile
Telephone +1 561 961-1900
Email Nochsner@TherapeuticsMD.com
Key Ratios
Profitability
EBIT Margin -857.9
EBITDA Margin -855.8
Pre-Tax Profit Margin -505.9
Profit Margin Cont -
Gross Margin 80.30
Profit Margin TOT -
Income Statements
Revenue $18,588,574
Revenue Per Share $0.0771
Revenue 3 Years $-4.32
Revenue 5 Years $3.45
Valuation Measures
PE Ratio -
Enterprise Value $673,459,672
Price To Sales 48.144253
Price To Free Cash -3.8
PE High Last 5 Years -
Price To Book 81.4
Price To Cash Flow 0.4
PE Low Last 5 Years -
Price To Tangible Book -39.7
Financial Strength
Total Debt To Equity 24.4
Int Coverage -15.5
Current Ratio 5.2
Leverage Ratio 2.9
Quick Ratio 4.8
Long Term Debt To Capital 0.96
Assets
Receivables Turnover 1.6
Invoice Turnover 0.80
Assets Turnover 0.10
Management Effectiveness
Return Assets -81.98
Return On Equity -405.66
Return On Capital -89.16
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
TXMD
Therapeuti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.